Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cyclophosphamide versus placebo in scleroderma lung disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cyclophosphamide versus placebo in scleroderma lung disease.
Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Aged, 80 and over
Autoimmune Diseases
Bronchoalveolar Lavage Fluid
Cyclophosphamide
Double-Blind Method
Female
Humans
Immunosuppressive Agents
Leukopenia
Lung Diseases, Interstitial
Male
Middle Aged
Regression Analysis
Respiratory Function Tests
Scleroderma, Systemic
Treatment Outcome
Vital Capacity
authors with profiles
Richard M. Silver
Marcy B. Bolster